In the present study we have demonstrated that the anti-DR5 antibody-drug conjugate (ADC), Zapadcine-1, could be one of such excellent agents for acute lymphocyte leukemia and solid tumor therapy. The gene discussed is TNFRSF10B; the disease is acute lymphoblastic leukemia.